VIP and osteochondritis dissecans: In GC-MS, the metabolome of OD patients reported 21 differential nasal metabolites in relation to NOD participants, with increased and decreased levels of 6 and 15 metabolites, respectively in OD patients (P < 0.05, VIP > 1, Figures 3B, C).